PAMELA CAMP: Open Payments
NPI 1689920787 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 47 payments from 14 companies in 2025. Trend: 2023 $1,102 · 2024 $1,165 · 2025 $1,267
Food & beverage: $1,197Education: $70
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $545 |
| Novartis Pharmaceuticals Corporation | 6 | $127 |
| GENZYME CORPORATION | 5 | $119 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| PFIZER INC. | 2 | $43 |
| Optinose US, Inc. | 2 | $40 |
| Grifols USA, LLC | 2 | $35 |
| CSL Behring | 1 | $26 |
Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, XOLAIR, FASENRA, Rhapsido, Xhance, NUCALA.
Industry payments across TN — which companies pay providers there.
